Medicaid GLP-1 coverage by state: 2026

    Based on KFF's January 2026 Medicaid survey and later state changes: October 2026

    Short answer

    Every state Medicaid program covers GLP-1 medicines for type 2 diabetes. Covering them for weight management is optional: KFF counted 13 state programs doing so in January 2026. Since then Utah’s pilot ended in June, Massachusetts ended ongoing coverage in July, and Rhode Island ended coverage on October 1, 2026, leaving 10 states. The table shows every state.

    Weight-management coverage in every state

    This is coverage under each state's fee-for-service Medicaid program, as surveyed by KFF, updated for changes reported since. Managed care plans generally follow the state's rules. Because coverage keeps changing, confirm with your state's preferred drug list or your plan.

    • Alabama
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Alaska
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Arizona
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Arkansas
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • California
      Ended
      Ended for adults on January 1, 2026; diabetes and some other approved uses still covered.
    • Colorado
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Connecticut
      Not covered
      Covers a weight-loss drug other than a GLP-1, per KFF.
    • Delaware
      Covered, with prior authorization
      Among the 13 states KFF counted in January 2026.
    • Florida
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Georgia
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Hawaii
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Idaho
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Illinois
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Indiana
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Iowa
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Kansas
      Covered, restricted
      Limited to people meeting severe-obesity criteria, with prior authorization.
    • Kentucky
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Louisiana
      Not covered
      Covers a weight-loss drug other than a GLP-1, per KFF.
    • Maine
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Maryland
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Massachusetts
      Ended
      Counted by KFF in January 2026; ongoing weight-management coverage ended in July 2026.
    • Michigan
      Covered, restricted
      Since January 2026, limited to morbid obesity after other treatments have been tried.
    • Minnesota
      Covered, with prior authorization
      Among the 13 states KFF counted in January 2026.
    • Mississippi
      Covered, with prior authorization
      Among the 13 states KFF counted in January 2026.
    • Missouri
      Covered, with prior authorization
      Added coverage; among the 13 states KFF counted in January 2026.
    • Montana
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Nebraska
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Nevada
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • New Hampshire
      Ended
      Ended on January 1, 2026.
    • New Jersey
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • New Mexico
      Not covered
      Covers a weight-loss drug other than a GLP-1, per KFF.
    • New York
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • North Carolina
      Covered, with prior authorization
      Paused in October 2025 during a state budget stalemate and restored in December 2025.
    • North Dakota
      Not covered
      Covers a weight-loss drug other than a GLP-1, per KFF.
    • Ohio
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Oklahoma
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Oregon
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Pennsylvania
      Ended
      Ended on January 1, 2026.
    • Rhode Island
      Ended
      Counted by KFF in January 2026; coverage for weight loss alone ended on October 1, 2026, under the state budget. Diabetes coverage continues.
    • South Carolina
      Ended
      Ended on January 1, 2026.
    • South Dakota
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Tennessee
      Covered, with prior authorization
      Added coverage from January 2026.
    • Texas
      Not covered
      Covers a weight-loss drug other than a GLP-1, per KFF.
    • Utah
      Ended
      Counted by KFF in January 2026; its legislative pilot covering GLP-1s for weight loss ended on June 30, 2026, and was not renewed.
    • Vermont
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Virginia
      Covered, restricted
      Criteria narrowed to people with the highest body mass index.
    • Washington
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Washington, D.C.
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • West Virginia
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    • Wisconsin
      Covered, with prior authorization
      Among the 13 states KFF counted in January 2026.
    • Wyoming
      Not covered
      Not among the states KFF counted as covering GLP-1s for weight management.
    Have a prescription?

    Upload it and licensed pharmacies reply with their own cash price. You pay the pharmacy, not us.

    Get quotes

    What every Medicaid program must cover

    Medicaid programs must cover nearly all FDA-approved medicines for their accepted medical uses, with a short list of optional exclusions that includes drugs for weight loss. So every state covers GLP-1s for type 2 diabetes, and states generally cannot exclude other approved uses, such as Wegovy to lower heart attack and stroke risk or Zepbound for obstructive sleep apnea, although they can require prior authorization. Only coverage for weight management on its own is a state choice.

    What prior authorization usually requires

    • A body mass index at or above the state’s threshold, sometimes with a weight-related condition such as high blood pressure or sleep apnea.
    • Documentation of diet, activity or a structured weight-management program.
    • For renewal, evidence of a minimum amount of weight lost by a set point.
    • In some states, trying a preferred drug first, such as Wegovy before Zepbound or the reverse.

    If your state does not cover it

    You can ask whether another approved use applies to you, such as heart disease or sleep apnea, which Medicaid programs generally must cover with prior authorization. If a request is denied, you have the right to an appeal and a state fair hearing. Manufacturer copay cards cannot be used with Medicaid, but the manufacturers’ self-pay programs remain an option if you choose to pay yourself.

    For how coverage works across other kinds of insurance, see GLP-1 coverage by insurance type, and for appeals, our guide to getting a GLP-1 covered.

    Frequently asked questions

    Does Medicaid cover Wegovy or Zepbound for weight loss?

    In some states. KFF counted 13 state Medicaid programs covering GLP-1s for obesity in January 2026, and several states have changed since. The table shows each state.

    Does Medicaid cover Ozempic?

    Yes, for type 2 diabetes, in every state, usually with prior authorization.

    Which states stopped covering GLP-1s for weight loss?

    California, New Hampshire, Pennsylvania and South Carolina ended coverage on January 1, 2026. Utah’s pilot ended on June 30, Massachusetts ended ongoing coverage in July, and Rhode Island ended coverage for weight loss alone on October 1, 2026. North Carolina paused coverage in October 2025 and restored it in December 2025.

    Can Medicaid deny Wegovy for heart disease?

    Medicaid programs generally must cover approved uses other than weight loss, including Wegovy to lower cardiovascular risk, though they can require prior authorization. If you are denied, you can appeal and request a fair hearing.

    How often does this change?

    Often. States revisit coverage in their budgets, so confirm with your state Medicaid program before relying on the table.

    Sources